Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GridAI TechnologiesGRDX +1.08%26 3-Year EBITDA Growth Rate is 85.10% as of Mar. 2026, which is 5% below its 10-year median of 89.45. GuruFocus rates GRDX with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 1,130 Biotechnology companies, GridAI Technologies ranks better than 97.26% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 85.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of GridAI Technologies was 93.80% per year. The lowest was 85.10% per year. And the median was 89.45% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
GridAI Technologies 3-Year EBITDA Growth Rate Related Terms
GRDX vs CELU, NRSN, ZIVO: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, GridAI Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GridAI Technologies 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GridAI Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where GridAI Technologies's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 85.10% mean?
GridAI Technologies (GRDX) has a 3-Year EBITDA Growth Rate of 85.10% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for GridAI Technologies and its competitors. This is near median its historical median of 89.45. Over the past decade, GridAI Technologies' 3-Year EBITDA Growth Rate has ranged from 85.10 to 93.80. According to the industry distribution chart, GridAI Technologies ranks #31 out of 1130 companies in the Biotechnology industry, placing it in the top 2.7%.
Is GridAI Technologies' 3-Year EBITDA Growth Rate too high?
GridAI Technologies' current 3-Year EBITDA Growth Rate of 85.10% is near median its 10-year median of 89.45. Over the past 10 years, this metric has ranged from a low of 85.10 to a high of 93.80. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.85. GridAI Technologies' value of 85.10% is 473.1% above this industry median. Based on the distribution chart, GridAI Technologies ranks #31 out of 1130 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GridAI Technologies has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does GridAI Technologies' 3-Year EBITDA Growth Rate compare to CELU and NRSN?
According to the Biotechnology industry distribution chart, GridAI Technologies ranks #31 out of 1130 companies for 3-Year EBITDA Growth Rate. This places GridAI Technologies in the top 3% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 14.85. GridAI Technologies' value of 85.10% is 473.1% above this benchmark. Historically, GridAI Technologies' own 3-Year EBITDA Growth Rate has ranged from 85.10 to 93.80 over the past decade. While the company's 10-year median is 89.45 vs. the industry median of 14.85, GridAI Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.85, based on 1,130 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GridAI Technologies's current 3-Year EBITDA Growth Rate of 85.10% is 473.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for GridAI Technologies and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GridAI Technologies's current 3-Year EBITDA Growth Rate is 85.10%, which is near median its own 10-year median of 89.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GridAI Technologies stock overvalued right now?
GridAI Technologies (GRDX) has a current 3-Year EBITDA Growth Rate of 85.10%. The current 3-Year EBITDA Growth Rate is 85.10%, which is near median its 10-year median of 89.45 and 473.1% above the Biotechnology industry median of 14.85. GridAI Technologies' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For GridAI Technologies (GRDX), the current 3-Year EBITDA Growth Rate is 85.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
26GF Score
Get the complete analysis for GRDX
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDX has been successfully added to your 
